Curtis Gale Oltmans, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 1,251 shares at $18.00 ($23K) on 2019-01-18, disclosed to the SEC on 2019-01-23.
Scheduled sale ($23k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARRY | SELL | 2019-02-07 | $800K | — | Filing → |
| ARRY | SELL | 2019-01-29 | $253K | — | Filing → |
| ARRY | SELL | 2019-01-17 | $712K | — | Filing → |